Eicosanoid profiling in colon cancer: emergence of a pattern.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.prostaglandins.2012.08.004PMID 22960430PMCID PMC3532570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models

  2012influential reference
• Multifaceted link between cancer and inflammation.

  2012influential reference
• Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.

  2012cited by this paper
• Is 15-LOX-1 a tumor suppressor?

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.

  2011cited by this paper
• Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation Evasion

  2011cited by this paper
• 15‐lipoxygenase‐1 exerts its tumor suppressive role by inhibiting nuclear factor‐kappa B via activation of PPAR gamma

  2011cited by this paper
• 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

  2011cited by this paper
• Profiling Lipoxygenase Metabolism in Specific Steps of Colorectal Tumorigenesis

  2010cited by this paper
• Honokiol inhibits gastric tumourigenesis by activation of 15‐lipoxygenase‐1 and consequent inhibition of peroxisome proliferator‐activated receptor‐γ and COX‐2‐dependent signals

  2010cited by this paper
• 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer

  2010cited by this paper
• The role of COX-2 in intestinal inflammation and colorectal cancer

  2010cited by this paper
• A Prospective Study of Dietary Polyunsaturated Fatty Acids and Colorectal Cancer Risk in Chinese Women

  2009cited by this paper
• Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

  2008cited by this paper
• Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon Cancer.

  2008cited by this paper
• Reversal of expression of 15‐lipoxygenase‐1 to cyclooxygenase‐2 is associated with development of colonic cancer

  2007cited by this paper
• 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.

  2007cited by this paper
• Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.

  2007cited by this paper
• Colon cancer, fatty acids and anti-inflammatory compounds

  2007cited by this paper
• Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids.

  2006cited by this paper
• Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

  2006cited by this paper
• Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice

  2006cited by this paper
• Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer.

  2006cited by this paper
• PROSTAGLANDINS AND CANCER

  2005cited by this paper
• Mechanisms for the Prevention of Gastrointestinal Cancer: The Role of Prostaglandin E2

  2005cited by this paper
• Tumor-Associated Down-Regulation of 15-Lipoxygenase-1 Is Reversed by Celecoxib in Colorectal Cancer

  2005cited by this paper
• The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.

  2005cited by this paper
• Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.

  2005cited by this paper
• Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase

  2004cited by this paper
• Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.

  2004cited by this paper
• Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ

  2004cited by this paper
• 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer.

  2004cited by this paper
• The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Apoptosis via Induction of 15-Lipoxygenase-1 in Colorectal Cancer Cells

  2004cited by this paper
• Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer.

  2003cited by this paper
• The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells

  2003cited by this paper
• 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer.

  2003cited by this paper
• Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells.

  2002cited by this paper
• Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.

  2002cited by this paper
• Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications.

  2002cited by this paper
• Modulation of epidermal tumor development caused by targeted overexpression of epidermis-type 12S-lipoxygenase.

  2002cited by this paper
• Dietary fat and cancer.

  2002cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

  2001cited by this paper
• Lipoxygenase modulation to reverse carcinogenesis.

  2001cited by this paper
• Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

  2001cited by this paper
• Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.

  2001cited by this paper
• 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

  2000cited by this paper
• 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.

  2000cited by this paper
• Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

  1999cited by this paper
• Lipoxygenases: Occurrence, Functions, Catalysis, and Acquisition of Substrate*

  1999cited by this paper
• Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

  1999cited by this paper
• Changes in expression of 15-lipoxygenase and prostaglandin-H synthase during differentiation of human tracheobronchial epithelial cells.

  1998cited by this paper
• Expression of 15-Lipoxygenase by Human Colorectal Carcinoma Caco-2 Cells during Apoptosis and Cell Differentiation*

  1998cited by this paper
• Discovery of a second 15S-lipoxygenase in humans.

  1997cited by this paper
• Arachidonate has protumor-promoting action that is inhibited by linoleate in mouse skin carcinogenesis.

  1996cited by this paper
• Regulation of the induction of ornithine decarboxylase in short-term rat colon organ culture by dexamethasone and 13-hydroxyoctadecadienoic acid (13-HODE).

  1993cited by this paper
• Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin.

  1991cited by this paper
• Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women.

  1990cited by this paper
• Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-hode).

  1990cited by this paper
• Dietary fat and cancer

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydroperoxides, autoxidation products of unsaturated fatty acids.

  1984cited by this paper
• Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture

  1983cited by this paper
• Polyunsaturated fat, cholesterol and large bowel tumorigenesis

  1977cited by this paper
• Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats.

  1975cited by this paper

• EPA, DHA, and resolvin effects on cancer risk: the underexplored mechanisms.

  2024cites this paper
• ALOX15, a new potential functional target of lung adenocarcinoma

  2023cites this paper
• Lipidomic Signatures for Colorectal Cancer Diagnosis and Progression Using UPLC-QTOF-ESI+MS

  2021cites this paper
• Celecoxib Colorectal Bioavailability and Chemopreventive Response in Familial Adenomatous Polyposis Patients

  2020cites this paper
• Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

  2020cites this paper
• Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients

  2019influential citation
• Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis

  2017cites this paper
• ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

  2017cites this paper
• Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors.

  2017cites this paper
• Impact of conjugated linoleic acid administered to rats prior and after carcinogenic agent on arachidonic and linoleic acid metabolites in serum and tumors.

  2017cites this paper
• The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity

  2017cites this paper
• New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution

  2017cites this paper
• LIPID METABOLISM IN COLORECTAL CANCER: ALTERATIONS, THERAPEUTIC OPPORTUNITIES, AND OUTLOOK ON MOLECULAR DIAGNOSTICS

  2016cites this paper
• Toll-like receptor 9 modifies intestinal serotonergic system.

  2016cites this paper
• Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension

  2015cites this paper
• Papel de la cascada del ácido araquidónico en el control de la proliferación de las células epiteliales intestinales humanas

  2015cites this paper
• Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model.

  2015cites this paper
• Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer

  2015cites this paper
• Eicosanoid pathway in colorectal cancer: Recent updates.

  2015cites this paper
• The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer

  2015cites this paper
• Linoleic acid and leukocyte inflammatory markers in periparturient dairy cows

  2014cites this paper
• Is there a place for practical chemoprevention of colorectal cancer in light of COX-2 heterogeneity?

  2014cites this paper
• Effect of conjugated linoleic acid mixture supplemented daily after carcinogen application on linoleic and arachidonic acid metabolites in rat serum and induced tumours.

  2014cites this paper
• Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line.

  2014cites this paper
• Dietary Polyunsaturated Fatty Acids and Inflammation: The Role of Phospholipid Biosynthesis

  2013cites this paper